4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-018628
Director sold 36,285 shares at an average $31.36 ($1,137,819)
From the SEC's structured data for this filing
Trades in this filing
SCHAFFER DAVID · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-20 | Sale : show line 1 in the form | −11,565 | $31.02 | $358,771 | 925,935 | D |
| 2021-10-21 | Sale : show line 2 in the form | −22,820 | $31.56 | $720,156 | 903,115 | D |
| 2021-10-22 | Sale : show line 3 in the form | −1,900 | $31.00 | $58,893 | 901,215 | D |
| Open-market sales · 36,285 sh · avg $31.36 · $1,137,819 | ||||||
Loading xslF345X03/doc1.xml…